Author
Prashant Ramesh Tembhare
Recent research
- Health & MedicineOpen access
Background Chimeric Antigen Receptor T-cell ( CAR T-cell) therapy is a promising treatment option for patients with refractory or relapsed B-cell malignancies. The success of this therapy depends on the efficient collection of lymphocytes (CD3 + T cells) through apheresis. This s...
- Health & MedicineOpen access
Abstract Chronic myeloid leukaemia (CML) is characterized by the presence of BCR::ABL1 showing favorable response to imatinib therapy. Complex rearrangements in CML are indicative of clonal evolution and often associated with disease progression and poor response to therapy. Cyto...